Keyword: biotech drugs

News

AstraZeneca Acquires US Biologics Plant from Amgen

14.09.2015 - As a first step toward doubling its manufacturing and production capacity for biologics in the US, AstraZeneca has acquired a high-tech biologics bulk manufacturing facility in...

News

AstraZeneca Buys Heart Firm Omthera for up to $443 Million

28.05.2013 - AstraZeneca is to buy Omthera Pharmaceuticals for as much as $443 million to build up its cardiovascular drug business, a priority area for Britain's second-biggest drugmaker. The...

News

Biotech Firms Evolve from Targets to Acquirers

08.05.2013 - Biotechnology companies that just a short time ago were viewed as takeover targets are now more likely to be buyers themselves after seeing their valuations soar on promising new...

News

Amgen First Quarter Sales Disappoint

24.04.2013 - Amgen on Tuesday reported first-quarter sales that fell short of Wall Street expectations for most of its biggest-selling medicines, and its shares fell more than 6%. Revenue for...

News

Roche Stays a Step Ahead of Copycat Drugmakers

25.03.2013 - Delays in developing copies of Roche's top-selling biotech drug are justifying the Swiss company's decision to stay out of biotech generics to focus on improved, patented versions...

News

FDA Halts Trials of Amgen Drug in Children, Cites Death

26.02.2013 - The U.S. Food and Drug Administration said on Tuesday it has stopped all pediatric clinical trials of Amgen's Sensipar after the death of a 14-year-old patient taking part in a...

News

Atox Bio to Seek Funds by Year-End for More Trials

04.09.2012 - Israeli biotechnology firm Atox Bio, developing a drug it hopes can treat severe infections such as those caused by flesh-eating bacteria and deadly viruses, expects to ask...

News

FDA Approves Teva Version of Amgen's Neupogen

30.08.2012 - U.S. drug regulators gave the nod to a Teva Pharmaceutical Industries drug that boosts the production of infection-fighting white blood cells in certain cancer patients receiving...